PROCEPT BioRobotics Corporation has grown revenue 49% a year over three years and 74% a year over five. Revenue growth, 3-year annual rate: +49% (Medical Devices median +12%). Revenue growth, 5-year rate: +74%, growth has slowed since the five-year average. Years of annual history on file: 6, FY2020 to FY2025, as filed.

PRCTPROCEPT BioRobotics Corporation

Healthcare

$18.40-51% 1Y

$18.40

$16.6952 weeks$39.15

Is it growing?

Mixed

Neither accelerating nor breaking down: nothing decisive, though revenue growing +23% year on year.

1 good, 1 neutral, 1 without data

Revenue trend+23% in a year

Trailing-twelve-month revenue vs a year earlier, from the company's own filings.

Margin direction−0.4 points operating

Trailing-twelve-month operating margin, -34.2% now against -33.8% a year earlier.

All from SEC EDGAR, as of Jun 30, 2026.

Where this answer is blind. These are trailing numbers from the filings, not forecasts: an acquisition or a one-off year can flatter them, so check the quarters.

Is PRCT growing?

PROCEPT BioRobotics Corporation has grown revenue 49% a year over three years and 74% a year over five.

+49%

Revenue growth, 3-year annual rate · Medical Devices median +12% · compounding fast · compounded from trailing twelve-month revenue

Revenue growth, 5-year rate: +74%
Revenue growth, 5-year rate · +49% over three · growth has slowed since the five-year average
Years of annual history on file: 6
Years of annual history on file · FY2020 to FY2025, as filed

Details›